PCLOF
Price
$0.03
Change
-$0.01 (-25.00%)
Updated
Aug 15 closing price
Capitalization
5.95M
PHCUF
Price
$5.87
Change
-$0.13 (-2.17%)
Updated
Aug 7 closing price
Capitalization
161.68M
Interact to see
Advertisement

PCLOF vs PHCUF

Header iconPCLOF vs PHCUF Comparison
Open Charts PCLOF vs PHCUFBanner chart's image
PHARMACIELO
Price$0.03
Change-$0.01 (-25.00%)
Volume$8.26K
Capitalization5.95M
Photocure ASA
Price$5.87
Change-$0.13 (-2.17%)
Volume$1K
Capitalization161.68M
PCLOF vs PHCUF Comparison Chart in %
Loading...
PCLOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHCUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PCLOF vs. PHCUF commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCLOF is a Hold and PHCUF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (PCLOF: $0.03 vs. PHCUF: $5.87)
Brand notoriety: PCLOF and PHCUF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: PCLOF: 17% vs. PHCUF: 312%
Market capitalization -- PCLOF: $5.95M vs. PHCUF: $161.68M
PCLOF [@Pharmaceuticals: Generic] is valued at $5.95M. PHCUF’s [@Pharmaceuticals: Generic] market capitalization is $161.68M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PCLOF’s FA Score shows that 0 FA rating(s) are green whilePHCUF’s FA Score has 1 green FA rating(s).

  • PCLOF’s FA Score: 0 green, 5 red.
  • PHCUF’s FA Score: 1 green, 4 red.
According to our system of comparison, PHCUF is a better buy in the long-term than PCLOF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PCLOF’s TA Score shows that 3 TA indicator(s) are bullish while PHCUF’s TA Score has 2 bullish TA indicator(s).

  • PCLOF’s TA Score: 3 bullish, 6 bearish.
  • PHCUF’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, PHCUF is a better buy in the short-term than PCLOF.

Price Growth

PCLOF (@Pharmaceuticals: Generic) experienced а +14.73% price change this week, while PHCUF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.26%. For the same industry, the average monthly price growth was +68.76%, and the average quarterly price growth was +80.82%.

Industries' Descriptions

@Pharmaceuticals: Generic (+6.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHCUF($162M) has a higher market cap than PCLOF($5.96M). PHCUF YTD gains are higher at: 4.907 vs. PCLOF (-39.494). PHCUF has higher annual earnings (EBITDA): 44.5M vs. PCLOF (-4.6M). PHCUF has more cash in the bank: 239M vs. PCLOF (148K). PHCUF has less debt than PCLOF: PHCUF (0) vs PCLOF (20.5M). PHCUF has higher revenues than PCLOF: PHCUF (523M) vs PCLOF (3.48M).
PCLOFPHCUFPCLOF / PHCUF
Capitalization5.96M162M4%
EBITDA-4.6M44.5M-10%
Gain YTD-39.4944.907-805%
P/E RatioN/A772.72-
Revenue3.48M523M1%
Total Cash148K239M0%
Total Debt20.5M0-
FUNDAMENTALS RATINGS
PCLOF vs PHCUF: Fundamental Ratings
PCLOF
PHCUF
OUTLOOK RATING
1..100
2493
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
98
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9991
PRICE GROWTH RATING
1..100
6544
P/E GROWTH RATING
1..100
1006
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PCLOF's Valuation (61) in the null industry is somewhat better than the same rating for PHCUF (98). This means that PCLOF’s stock grew somewhat faster than PHCUF’s over the last 12 months.

PCLOF's Profit vs Risk Rating (100) in the null industry is in the same range as PHCUF (100). This means that PCLOF’s stock grew similarly to PHCUF’s over the last 12 months.

PHCUF's SMR Rating (91) in the null industry is in the same range as PCLOF (99). This means that PHCUF’s stock grew similarly to PCLOF’s over the last 12 months.

PHCUF's Price Growth Rating (44) in the null industry is in the same range as PCLOF (65). This means that PHCUF’s stock grew similarly to PCLOF’s over the last 12 months.

PHCUF's P/E Growth Rating (6) in the null industry is significantly better than the same rating for PCLOF (100). This means that PHCUF’s stock grew significantly faster than PCLOF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PCLOFPHCUF
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
22%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
40%
Momentum
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
24%
MACD
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
30%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
30%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
26%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 5 days ago
13%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
41%
View a ticker or compare two or three
Interact to see
Advertisement
PCLOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHCUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYMIX59.370.24
+0.41%
Rydex Telecommunications Inv
BTBFX64.33-0.13
-0.20%
Boston Trust Asset Management
SVSPX282.51-0.75
-0.26%
State Street S&P 500 Index N
TWCIX132.25-0.43
-0.32%
American Century Select Inv
TLARX12.28-0.05
-0.41%
Transamerica Large Core ESG R

PCLOF and

Correlation & Price change

A.I.dvisor tells us that PCLOF and MSTH have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PCLOF and MSTH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCLOF
1D Price
Change %
PCLOF100%
-23.05%
MSTH - PCLOF
23%
Poorly correlated
N/A
OWPC - PCLOF
14%
Poorly correlated
+25.00%
PHCUF - PCLOF
13%
Poorly correlated
N/A
ROMJF - PCLOF
8%
Poorly correlated
-2.03%
OILFF - PCLOF
6%
Poorly correlated
+0.26%
More

PHCUF and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHCUF has been loosely correlated with HLTRF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PHCUF jumps, then HLTRF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHCUF
1D Price
Change %
PHCUF100%
N/A
HLTRF - PHCUF
38%
Loosely correlated
+0.27%
INCR - PHCUF
26%
Poorly correlated
-1.81%
ELAN - PHCUF
24%
Poorly correlated
-0.22%
MKKGY - PHCUF
22%
Poorly correlated
+2.36%
MKGAF - PHCUF
20%
Poorly correlated
+1.94%
More